Dr. David Shearer Nominated For Drug Information Association Board Of Directors

PR Log (Press Release) – Dec 02, 2008 – RALEIGH, N.C. – Tom Sturgis, president of Integrated Clinical Trial Services (ICTS), a full-service patient enrollment firm that utilizes more than 300 contract employees internationally to provide clinical trial patient recruitment, enrollment, retention and adherence, has announced that David M. Shearer, MD, chief medical officer and vice president of clinical operations for the firm, has been nominated for the Drug Information Association Board of Directors.  The board is responsible for setting the strategic direction for the organization, as well as providing fiscal oversight, enhancing DIA’s public standing and strengthening DIA’s programs and services.  In addition to attending quarterly, two-day board meetings, members will attend both an annual meeting and Euro meeting as a part of their service to the board.

Dr. Shearer is actively involved with the American Diabetes Association (ADA) and the American Medical Student Association, and frequently volunteers his time with emergency medicine groups as a certified provider of advanced cardiac life support and emergency trauma medicine.  He joined ICTS in June and is responsible for overseeing all medical components of ICTS-affiliated clinical trials, which include such duties as protocol review and quality assurance in patient recruitment and the education of physicians for the trials.

Related Links:
www.integratedtrials.com
www.diahome.org
www.mmimarketing.com

News Facts:
•   Tom Sturgis, president of Integrated Clinical Trial Services (ICTS), a full-service patient enrollment firm that utilizes more than 300 contract employees internationally to provide clinical trial patient recruitment, enrollment, retention and adherence, has announced that David M. Shearer, MD, chief medical officer and vice president of clinical operations for the firm, has been nominated for the Drug Information Association Board of Directors.
•   The board is responsible for setting the strategic direction for the organization, as well as providing fiscal oversight, enhancing DIA’s public standing and strengthening DIA’s programs and services.
•   In addition to attending quarterly, two-day board meetings, members will attend both an annual meeting and Euro meeting as a part of their service to the board.
•   Dr. Shearer is actively involved with the American Diabetes Association (ADA) and the American Medical Student Association, and frequently volunteers his time with emergency medicine groups as a certified provider of advanced cardiac life support and emergency trauma medicine.
•   He joined ICTS in June and is responsible for overseeing all medical components of ICTS-affiliated clinical trials, which include such duties as protocol review and quality assurance in patient recruitment and the education of physicians for the trials.

Quotes:
“We are excited about Dr. Shearer’s nomination to the DIA Board of Directors,” said Sturgis.  “His experience and extensive knowledge of the pharmaceutical industry makes him a valuable resource and we hope that DIA will select him for their board.”

About Integrated Clinical Trial Services:
Integrated Clinical Trial Services is a creative, innovative and flexible partner for clinical trial patient recruitment, enrollment, retention and adherence.  The full-service firm utilizes more than 300 contract employees internationally to provide patient enrollment feasibility, recruitment strategy, consulting, market research and protocol review, project management, concept design and production, media placement, community resource support, compliance and retention, and more.  The Integrated Clinical Trial Services management team has completed more than 300 successful patient recruitment programs and combines for more than 60 years of active involvement in patient accrual.  A successful trial depends on the quality of the underlying recruitment plan and Integrated Clinical Trial Services is dedicated to constructing the right solution based upon each client’s protocol and needs.  For more information please call (919) 388-3964 or visit the Web site at www.integratedtrials.com.

Keywords:
Integrated Clinical Trial Services, ICTS, Tom Sturgis, clinical trial, clinical research industry, patient enrollment, clinical trial sponsors, recruitment strategy, compliance, retention, David M. Shearer, MD, Drug Information Association, DIA, American Diabetes Association, ADA, American Medical Student Association

Patty Briguglio
MMI Associates, Inc.
(919) 233-6600
patty@mmimarketing.com
PR Firms Raleigh, NC

(end)